The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance.
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D001205:Ascorbic Acid / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000378:metabolism; D007109:Immunity; D008214:Lymphocytes / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology / Q000378:metabolism; D013256:Steroids / Q000378:metabolism; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D013256:Steroids; D006821:Hyaluronoglucosaminidase; D001205:Ascorbic Acid